Benzinga's Top Upgrades, Downgrades For May 27, 2020

Upgrades

• Evercore ISI Group upgraded the stock for Dentsply Sirona Inc XRAY from In-Line to Outperform. In the first quarter, Dentsply Sirona showed an EPS of $0.43, compared to $0.49 from the year-ago quarter. The stock has a 52-week-high of $60.87 and a 52-week-low of $31.57. Dentsply Sirona's stock last closed at $45.33 per share.
• For NIO Inc NIO, JP Morgan upgraded the stock from Underweight to Neutral. NIO earned ($0.39) in the fourth quarter, compared to ($0.47) in the year-ago quarter. The stock has a 52-week-high of $5.65 and a 52-week-low of $1.19. NIO's stock last closed at $3.83 per share.
• For Sensata Technologies Holding PLC ST, Morgan Stanley upgraded the stock from Underweight to Equal-Weight. Sensata Technologies earned $0.53 in the first quarter, compared to $0.85 in the year-ago quarter. The stock has a 52-week-high of $54.72 and a 52-week-low of $18.25. Sensata Technologies's stock last closed at $36.37 per share.
• Goldman Sachs changed the rating for Jack In The Box Inc JACK from Sell to Neutral. For the second quarter, Jack In The Box had an EPS of $0.50, compared to year-ago quarter EPS of $0.99. The stock has a 52-week-high of $93.12 and a 52-week-low of $16.81. Jack In The Box's stock last closed at $65.31 per share.
• Morgan Stanley changed the rating for Bilibili Inc BILI from Equal-Weight to Overweight. Bilibili earned ($0.20) in the first quarter, compared to ($0.06) in the year-ago quarter. The stock has a 52-week-high of $36.47 and a 52-week-low of $13.23. Bilibili's stock last closed at $33.13 per share.
• MKM Partners upgraded the stock for AMC Entertainment Holdings Inc AMC from Sell to Neutral. For the fourth quarter, AMC Entertainment had an EPS of $0.35, compared to year-ago quarter EPS of $0.18. The stock has a 52-week-high of $13.06 and a 52-week-low of $1.95. AMC Entertainment's stock last closed at $5.10 per share.
• JP Morgan upgraded the stock for TransDigm Group Inc TDG from Underweight to Neutral. In the second quarter, TransDigm Gr showed an EPS of $5.10, compared to $4.21 from the year-ago quarter. The stock has a 52-week-high of $673.51 and a 52-week-low of $200.06. TransDigm Gr's stock last closed at $402.58 per share.

Downgrades

• For Merus NV MRUS, RBC Capital downgraded the stock from Outperform to Sector Perform. Merus earned ($0.68) in the first quarter, compared to ($0.29) in the year-ago quarter. The stock has a 52-week-high of $20.95 and a 52-week-low of $10.19. Merus's stock last closed at $15.36 per share.
• Deutsche Bank downgraded the stock for LATAM Airlines Group SA LTM from Hold to Sell. LATAM Airlines Group earned $0.37 in the fourth quarter, compared to $0.25 in the year-ago quarter. The stock has a 52-week-high of $12.15 and a 52-week-low of $1.00. LATAM Airlines Group's stock last closed at $1.68 per share.
• Stifel changed the rating for Bio-Techne Corp TECH from Buy to Hold. In the third quarter, Bio-Techne showed an EPS of $1.39, compared to $1.21 from the year-ago quarter. The stock has a 52-week-high of $282.52 and a 52-week-low of $155.17. Bio-Techne's stock last closed at $260.65 per share.
• Barclays downgraded the stock for Pinduoduo Inc PDD from Overweight to Equal-Weight. Pinduoduo earned ($0.39) in the first quarter, compared to ($0.20) in the year-ago quarter. The stock has a 52-week-high of $69.69 and a 52-week-low of $18.46. Pinduoduo's stock last closed at $64.89 per share.
• For Hyatt Hotels Corp H, Baird downgraded the stock from Outperform to Neutral. In the first quarter, Hyatt Hotels showed an EPS of ($0.35), compared to $0.45 from the year-ago quarter. The stock has a 52-week-high of $94.98 and a 52-week-low of $24.02. Hyatt Hotels's stock last closed at $56.54 per share.
• Mizuho changed the rating for FirstEnergy Corp FE from Buy to Neutral. FirstEnergy earned $0.66 in the first quarter, compared to $0.67 in the year-ago quarter. The stock has a 52-week-high of $52.52 and a 52-week-low of $32.00. FirstEnergy's stock last closed at $40.70 per share.
• For Pearson PLC PSO, Berenberg downgraded the stock from Hold to Sell. The stock has a 52-week-high of $11.51 and a 52-week-low of $5.08. Pearson's stock last closed at $5.75 per share.

Initiations

• Alliance Global Partners initiated coverage on PDS Biotechnology Corp PDSB with a Buy rating. The price target for PDS Biotechnology is set at $4.00. In the first quarter, PDS Biotechnology showed an EPS of ($0.39), compared to ($1.06) from the year-ago quarter. The stock has a 52-week-high of $7.84 and a 52-week-low of $0.62. PDS Biotechnology's stock last closed at $1.17 per share.
• Deutsche Bank initiated coverage on Chipotle Mexican Grill Inc CMG with a Hold rating. The price target for Chipotle Mexican Grill is set at $1132.00. Chipotle Mexican Grill earned $3.08 in the first quarter, compared to $3.40 in the year-ago quarter. The stock has a 52-week-high of $1087.00 and a 52-week-low of $415.00. Chipotle Mexican Grill's stock last closed at $1016.80 per share.
• With a rating of Overweight, Wells Fargo initiated coverage on ChemoCentryx Inc CCXI. The price target is set at $79.00 for ChemoCentryx. ChemoCentryx earned ($0.35) in the first quarter, compared to ($0.23) in the year-ago quarter. The stock has a 52-week-high of $61.25 and a 52-week-low of $6.16. ChemoCentryx's stock last closed at $59.20 per share.
• For Pacira BioSciences Inc PCRX, Guggenheim initiated coverage, by setting the current rating at Neutral. Pacira BioSciences earned $0.53 in the first quarter, compared to $0.22 in the year-ago quarter. The stock has a 52-week-high of $51.35 and a 52-week-low of $27.46. Pacira BioSciences's stock last closed at $44.54 per share.
• With a rating of Buy, Guggenheim initiated coverage on Heron Therapeutics Inc HRTX. The price target is set at $24.00 for Heron Therapeutics. For the first quarter, Heron Therapeutics had an EPS of ($0.57), compared to year-ago quarter EPS of ($0.80). The stock has a 52-week-high of $26.81 and a 52-week-low of $9.60. Heron Therapeutics's stock last closed at $18.44 per share.
• With a rating of Buy, Jefferies initiated coverage on Freshpet Inc FRPT. The price target is set at $86.00 for Freshpet. Freshpet earned ($0.07) in the first quarter, compared to ($0.10) in the year-ago quarter. The stock has a 52-week-high of $81.29 and a 52-week-low of $35.95. Freshpet's stock last closed at $70.92 per share.
• With a rating of Buy, Guggenheim initiated coverage on Flexion Therapeutics Inc FLXN. The price target is set at $20.00 for Flexion Therapeutics. In the first quarter, Flexion Therapeutics showed an EPS of ($0.95), compared to ($1.09) from the year-ago quarter. The stock has a 52-week-high of $22.98 and a 52-week-low of $5.01. Flexion Therapeutics's stock last closed at $9.69 per share.
• BTIG initiated coverage on Donnelley Financial Solutions Inc DFIN with a Buy rating. The price target for Donnelley Financial Solns is set at $11.00. Donnelley Financial Solns earned $0.21 in the first quarter, compared to $0.06 in the year-ago quarter. The stock has a 52-week-high of $14.77 and a 52-week-low of $4.04. Donnelley Financial Solns's stock last closed at $7.84 per share.
• For Collegium Pharmaceutical Inc COLL, Guggenheim initiated coverage, by setting the current rating at Neutral. For the first quarter, Collegium Pharmaceutical had an EPS of $0.01, compared to year-ago quarter EPS of ($0.29). The stock has a 52-week-high of $25.59 and a 52-week-low of $10.01. Collegium Pharmaceutical's stock last closed at $23.43 per share.